Visiting Assistant Professor of Chemistry
Joined Connecticut College: 2013
B.A., Kalamazoo College
Ph.D., Pharmaceutics, University of Michigan
• Pharmaceuticals • Pharmacokinetics
Kevin Johnson is president and founder of Intellipharm, LLC, a a 10-year career as a research scientist and principal research investigator for Pfizer Inc's Department of Pharmaceutical R&D. He previously taught pharmacokinetics at the University of Connecticut School of Pharmacy as an adjunct professor, and taught chemistry at Norwich Free Academy in Norwich, Conn.
Johnson, K.C. "Comparison of methods for predicting dissolution and the theoretical implications of particle-size-dependent solubility." J Pharm Sci 101:681-689. (2012)
- Johnson, K.C. 2009. Particle size of drug substance and product content uniformity – theoretical considerations. In Zheng J, editor. Formulation and analytical development for low-dose oral drug products, copyright 2009 by John Wiley & Sons. pp 49-62.
- Johnson, K.C. 2007. Dissolution: fundamentals of in vitro release and the biopharmaceutics classificationsystem. In Chilukuri DM, Sunkara G, Young D, editors. Pharmaceutical product development in vitroinvivo correlation, New York copyright 2007 by Informa Healthcare USA, Inc. pp 1-28.
Johnson is a member of the Editorial Advisory Board for the Journal of Pharmaceutical Sciences, the American Association of Pharmaceutical Scientists and the American Chemical Society.